• Pfizer Crashes After Slashing Profit Guidance By More Than Half On Collapsing Demand For Covid Meds

    October 14, 2023
    0

    Please Follow us on Gab, Minds, Telegram, Rumble, GETTR, Truth Social, Twitter 

    Pfizer just lobbed a legendary Friday evening bomb when it slashed its revenue and earnings forecasts for the year as it agreed to take returns from the US of its Covid antiviral Paxlovid amid collapsing demand.

    Waiting patiently until after the market closed on Friday, the company said it now sees 2023 revenue of only $58 billion to $61 billion, down $9 billion from its previous estimate of $67 billion to $70 billion. 

    The drugmaker said adjusted EPS are now expected to be between $1.45 a share and $1.65 a share, down by more than half from its previous earnings forecast of $3.25 a share to $3.45 a share...

    To read more visit Zero Hedge.

    ‘NO AD’ subscription for CDM!  Sign up here and support real investigative journalism and help save the republic!  

    Author

    Avatar photo

    CDM Staff

    The mission at Creative Destruction Media is to be the catalyst for the "process of industrial mutation that incessantly revolutionizes the economic structure from within, incessantly destroying the old one, incessantly creating a new one."
  • Subscribe
    Notify of
    guest

    0 Comments
    Inline Feedbacks
    View all comments
    magnifierchevron-right

    Subscribe to our evening newsletter to stay informed during these challenging times!!